{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/scabies/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"c1f2f20f-1192-5385-b710-2f4aeb402bc9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field 10d1cac3-c069-45ef-94b9-a7f2018913aa --><h2>Evidence exclusion criteria</h2><!-- end field 10d1cac3-c069-45ef-94b9-a7f2018913aa -->","summary":null,"htmlStringContent":"<!-- begin item c139532c-e5aa-4903-99e3-a7f20187a3cf --><!-- begin field ecd07d08-a8da-48b0-a049-a7f2018913aa --><h2>Our policy</h2><!-- end field ecd07d08-a8da-48b0-a049-a7f2018913aa --><!-- begin field 8a31301d-6805-414b-a187-a7f2018913aa --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field 8a31301d-6805-414b-a187-a7f2018913aa --><!-- begin field aefb0041-3747-4a76-a5db-a7f2018913aa --><h2>Standard exclusions for scoping literature:</h2><!-- end field aefb0041-3747-4a76-a5db-a7f2018913aa --><!-- begin field 73a0dfcc-f35e-44fc-9861-a7f2018913aa --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field 73a0dfcc-f35e-44fc-9861-a7f2018913aa --><!-- begin field fb5eef4f-0a26-4fd8-aa3d-a7f2018913aa --><h2>Possible exclusions for reviewed literature:</h2><!-- end field fb5eef4f-0a26-4fd8-aa3d-a7f2018913aa --><!-- begin field 5f31ba62-4adb-4843-a800-a7f2018913aa --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field 5f31ba62-4adb-4843-a800-a7f2018913aa --><!-- end item c139532c-e5aa-4903-99e3-a7f20187a3cf -->","topic":{"id":"2239c8be-00a0-56aa-8fe9-0467b238f0c4","topicId":"da2824e2-e1de-4303-9c52-8224034ff953","topicName":"Scabies","slug":"scabies","lastRevised":"Last revised in NovemberÂ 2017","chapters":[{"id":"da8e838e-f347-56db-afd1-75fbd32ad909","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8230d8c6-45b3-5bdb-8cc8-3c1c2b823449","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"a4632036-ac3e-5da5-9aff-ee789e83a368","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f3a44b9a-af69-5c7d-9a47-6dc02fafa709","slug":"changes","fullItemName":"Changes"},{"id":"4d9cd925-2e05-5383-933f-f483f2ed7fdc","slug":"update","fullItemName":"Update"}]},{"id":"a65309c1-f446-573c-a812-cd9a67f28cc7","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a68dada3-3034-53ad-9477-23904345690e","slug":"goals","fullItemName":"Goals"},{"id":"bbbd25ab-ead3-5868-b558-5283d76c73ea","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c05af2ff-93bf-5065-acf0-511a278d4cdf","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"b592bb65-acf3-54c5-9e50-f1d986ef2099","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6fdf1f82-f5bd-5ebe-b440-d5e2b673f214","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7c704acb-f3b9-5169-b8e6-a401a805fb9f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e967b469-438f-5a3c-b576-bb55b8cd46c0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"5119a491-fd63-525d-9787-b77adf1ad31a","slug":"definition","fullItemName":"Definition"},{"id":"d4abdef1-d529-5524-a289-d515c8900234","slug":"prevalence","fullItemName":"Prevalence"},{"id":"8bc35f21-913e-5a50-b011-2b928b93c033","slug":"transmission","fullItemName":"Transmission"},{"id":"1a3cadf7-aa8c-5437-9b8c-ebf6a885e18d","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"2065f768-9383-5d5e-8dd5-a0411d51dade","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"783dffe4-5b71-5b67-8b76-aa6d05b04591","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"9fde1af7-a79f-56cf-b595-ac0691f21b5f","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"177fab9d-042e-5ed5-bef2-4b96c7157717","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"},{"id":"a4fb57b7-6e89-5bc6-8768-5a2a59312f92","slug":"basis-for-recommendation-501","fullItemName":"Basis for recommendation"}]},{"id":"f0095d1b-7de8-51f8-86f9-51236504dc2c","fullItemName":"Management","slug":"management","subChapters":[{"id":"b8090f99-a407-59d0-bd90-cad808bf8bbf","slug":"management-of-scabies","fullItemName":"Scenario: Management of scabies"}]},{"id":"a3c66bd0-4e63-5096-98e7-3648f3a19fa5","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"82606908-d488-536f-badf-4311c083f9f2","slug":"insecticides","fullItemName":"Insecticides"},{"id":"e0ff263e-9d39-5b6e-a192-b3c23f35b8e2","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"},{"id":"87495d38-99d2-59af-ab1b-3701df31a332","slug":"chlorphenamine-hydroxyzine","fullItemName":"Chlorphenamine and hydroxyzine:"},{"id":"384c43f2-9128-5f2d-92dd-f064f115544a","slug":"crotamiton-10percent-cream","fullItemName":"Crotamiton 10% cream"}]},{"id":"d23e8a1b-527a-5b4e-bc6e-1550c1d7b7f7","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"bf5d0fd9-3845-54be-8307-14fee2b8fe46","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"24a603a9-c1be-5619-9cab-6e8cc775ec79","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"862928da-a3ad-5b3c-b1fa-c221c79d2e0a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"c1f2f20f-1192-5385-b710-2f4aeb402bc9","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"42e0b79b-5cd7-53cd-bc72-422e96a7aaf4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"324db100-c4d0-5d57-9a1f-c8487c474f9e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"860692e0-5ebd-5bb6-8862-8c22738325ca","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"bf5d0fd9-3845-54be-8307-14fee2b8fe46","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}